Revance Therapeutics Inc (NASDAQ: RVNC) has reported topline data from JUNIPER Phase 2 study evaluating DaxibotulinumtoxinA for Injection to treat adults with moderate to severe upper limb spasticity.

Upper limb spasticity, or involuntary overactivity of muscles caused by upper motor neuron damage to the brain or spinal cord, is a common complication of stroke and is often associated with ...

The FDA has approved an expanded indication for Botox for the treatment of adults with upper limb spasticity. News ... significant reduction in thumb flexor muscle tone of 1.0 Botox ...

Long-acting symptom relief is a current unmet need for upper limb spasticity patients as the benefits of currently approved botulinum toxin treatments lasts for a median duration of approximately ...

THE term "varicose veins" customarily suggests, immediately, and almost exclusively, abnormal dilatations and tortuosities of the saphenous veins of the lower extremity. If one then stops to reflec ...

Upper-arm flab seems to pile on as the years roll by, but don’t set fire to those sleeveless shirts just yet. We asked accomplished local trainer Eric Grimes, owner and operator of Yonkers-based Iron ...

Merz North America announced that Xeomin (incobotulinumtoxinA) has been approved by the Food and Drug Administration (FDA) for the treatment of upper limb spasticity in adults.

With this approval, DYSPORT THERAPEUTIC now has the broadest label of all approved botulinum neurotoxins for spasticity, which includes both upper and lower limb spasticity in adults, as well as ...